Biologics, engineered for better control
At TROYA, we use protein engineering to control the activity of medicines, improving their potency and safety.
Our biotherapeutics platform is based on a novel, natural scaffold that effectively activates the drug at the disease site – sparing other parts of the body.
Seandean L. Harwood, PhD
Ulrik B. Nielsen, PhD
Jan Enghild, PhD